Carbon dioxide absorbents containing potassium hydroxide produce much larger concentrations of Compound A from sevoflurane in clinical practice

Anesthesia and Analgesia

Volumn 91, Issue 1, 2000, Pages 220-224

  Yamakage, Michiaki ^a   Yamada, Shigeyuki ^a   Chen, Xiangdong ^a   Iwasaki, Sohshi ^a   Tsujiguchi, Naoki ^a   Namiki, Akiyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; POTASSIUM HYDROXIDE; SEVOFLURANE; SODIUM HYDROXIDE;

ABSORPTION; ADULT; ARTICLE; CARBON DIOXIDE MEASUREMENT; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEVICE; FEMALE; GAS CHROMATOGRAPHY; GAS FLOW; HUMAN; INHALATION ANESTHESIA; MALE; PRIORITY JOURNAL;

EID: 0033934433     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200007000-00041     Document Type: Article

References (27)

1. Wallin R, Regan B, Napoli M, Stern I. Sevoflurane, a new inhalational anesthetic agent. Anesth Analg 1975;54:758-65.
2. Bito H, Ikeda K. Closed-circuit anesthesia with sevoflurane in humans: effects on renal and hepatic function and concentrations of breakdown products with soda lime in the circuit. Anesthesiology 1994;80:71-6.
3. Gonsowski CT, Laster MJ, Eger EI II, et al. Toxicity of compound A in rats: effect of increasing duration of administration. Anesthesiology 1994;80:566-73.
4. Gonsowski CT, Laster MJ, Eger EI II, et al. Toxicity of compound A in rats: effect of a 3-hour administration. Anesthesiology 1994;80:556-65.
5. Keller KA, Callan C, Prokocimer P, et al. Inhalation toxicity study of a haloalkene degradant of sevoflurane, Compound A (PIEE), in Sprague-Dayley rats. Anesthesiology 1995;83: 1220-32.
6. Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology 1997;86:1231-7.
7. Kharasch ED, Frink EJ Jr, Zager R, et al. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997;86: 1238-53.
8. Higuchi H, Sumita S, Wada H, et al. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity. Anesthesiology 1998;89:307-22.
9. Tung A, Jacobsohn E. A case of nonoliguric renal failure after general anesthesia with sevoflurane and desflurane. Anesth Analg 1997;85:1407-9.
10. Baxter AD. Low and minimal flow inhalational anaesthesia. Can J Anaesth 1997;44:643-53.
11. Bito H, Ikeda K. Effects of total flow rate on the concentration of degradation products generated by reaction between sevoflurane and soda lime. Br J Anaesth 1995;74:667-9.
12. Bito H, Ikeda K. Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents. Anesthesiology 1994; 81:340-5.
13. Fang ZX, Eger EI II. Factors affecting the concentration of compound A resulting from the degradation of sevoflurane by soda lime and Baralyme in a standard anesthetic circuit. Anesth Analg 1995;81:564-8.
14. Mazze RI, Jamison RL. Low-flow (1 l/min) sevoflurane: is it safe? Anesthesiology 1997;86:1225-7.
15. Neumann MA, Laster MJ, Weiskopf RB, et al. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption. Anesth Analg 1999;89:768-73.
16. Murray JM, Renfrew CW, Bedi A, et al. Amsorb: a new carbon dioxide absorbent for use in anesthetic breathing systems. Anesthesiology 1999;91:1342-8.
17. Morio M, Fujii K, Satoh N, et al. Reaction of sevoflurane and its degradation products with soda lime. Anesthesiology 1992;77: 1155-64.
18. Kharasch ED, Hoffman GM, Thorning D, et al. Role of the renal cysteine conjugate β-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiology 1998;88:1624-33.
19. Eger EI II, Koblin DD, Bowland T, et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997;84:160-8.
20. Goldberg ME, Cantillo J, Gratz I, et al. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. Anesth Analg 1999;88: 437-45.
21. Ebert TJ, Frink EJ Jr, Kharasch ED. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 1998;88:601-10.
22. Cunningham DD, Huang S, Webster J, et al. Sevoflurane degradation to compound A in anaesthesia breathing systems. Br J Anaesth 1996;77:537-43.
23. Berry PD, Sessler DI, Larson MD. Severe carbon monoxide poisoning during desflurane anesthesia. Anesthesiology 1999; 90:613-6.
24. Lentz RE. CO poisoning during anesthesia poses puzzles. J Clin Monit 1995;11:67-71.
25. Frink EJ Jr, Nogami WM, Morgan SE, Salmon RC. High carboxyhemoglobin concentrations occur in swine during desflurane anesthesia in the presence of partially dried carbon dioxide absorbents. Anesthesiology 1997;87:308-16.
26. Stewart RD. The effect of carbon monoxide on humans. J Occup Med 1976;18:304-9.
27. Baxter PJ, Carton K, Kharasch ED. Mechanistic aspects of carbon monoxide formation from volatile anesthetics. Anesthesiology 1998;89:929-41.